1MacFarlane M, Ahmad S, Srinivasula M, et al. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem, 1997,272:25417.
2Emery JG, McDonnell P, Burke MB, et al. Ostroprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem,1998,273: 14363-14367.
3Yamashita Y. Shimada M. Tanaka S, et al. Electroporation mediated tumor necrosis factor related apoptosis inducing ligand (TRAIL)Apo2L gene therapy for hepatocellular carcinoma. Hum Gene Ther.2002.13:275-286.
4Okano H, Shiraki K. Inoue H, et al.Peroxisome proliferator activated receptor gamma augments tumor necrosis factor family induced apoptosis in hepatocellular carcinoma. Anticancer Drugs, 2002,13:59-65.
5Yamanaka T, Shiraki K, Sugimoto K, et al. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology,2000,32:482-490.
6Shin EC. Seong YR. Kim CH, et al.Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolishecd by cisplatin. Exp Mol Med,2002,34 : 114-122.
7Pan G, Rorke K, Chinnalyan AM, et al. The receptor for tilecytotoxic ligand TRAIL. Science, 1997,276 ; 111-113.
8Scheridan JP, Marster SA, Pitti PM, et al. Control of TRAil,-induced apoptosis by a family of signaling and decoy receptor.Science, 1997,277 .. 818-821.
9He SQ, Chen Y, Chen XP, et al. Antitumor effects of solable TRAIL in human hepatocellular carcinoma. Zhonghua zhong Liu Za Zhi,2003,25:116-I19.
10Engels IH, Totzke G, Fischer U, et al. Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a Caspase- 3 dependent manner. Mol Cell Biol, 2005,25 ; 2808-2818.
